FINWIRES · TerminalLIVE
FINWIRES

Immutep Reports Survival Benefit Linked to Immune Response in Efti Clinical Trial Analysis

By

Immutep (ASX:IMM) said a systematic evaluation of five clinical trials of eftilagimod alfa (efti), an antigen-presenting cell (APC) activator, in combination with standard-of-care therapies in late-stage cancer patients showed a significant increase in circulating absolute lymphocyte count (ALC) compared to standard-of-care alone, according to a Thursday Australian bourse filing.

The company said increased ALC was significantly associated with improved clinical outcomes, with ALC responders in the efti plus standard-of-care group showing a clinically meaningful median overall survival improvement of 7.7 months compared to ALC non-responders, with no corresponding association observed in the standard-of-care alone group.

"The findings link the immune-activating effect of efti measured in patients' blood with meaningful and significant survival improvements observed in previous clinical trials," said Immutep's Chief Scientific Officer, Frederic Triebel, adding that the studies highlighted a key connection with efti's mechanism of action and clinical efficacy.

The company's shares fell 2% in recent Thursday trade.

Related Articles

Asia

Tianyuan DIC Chair Released From Detention; Shares Jump 7%

Shenzhen Tianyuan DIC Information Technology (SHE:300047) said Chair Chen You was released from residential detention.Chen was originally detained by the Leping City Supervisory Commission in Jiangxi, China, in December 2025, according to a Thursday filing with the Shenzhen bourse.Chen will resume his normal duties.Shares of the information technology company rose 7% in recent trade.

$SHE:300047
Asia

Singapore Airlines, Air New Zealand to Expand Joint Network

Singapore Airlines (SGX:C6L) and New Zealand (NZE:AIR, ASX:AIZ) agreed to expand their joint network by introducing new non-stop flights into Christchurch and increasing capacity into Auckland, according to a company release on Thursday.Under the new arrangement, Air New Zealand will launch three weekly flights between Singapore and Christchurch during the Northern Winter season, taking the Christchurch operations to 12 weekly services.The New Zealand flight operator will also add four weekly Auckland services during the period.Air New Zealand is expecting a 17% increase in its overall seat capacity between Singapore and New Zealand from late October.

$ASX:AIZ$NZE:AIR$SGX:C6L
Asia

Air China Raises 20 Billion Yuan via Private Placement to Parent; Hong Kong Shares Slide 3%

Air China (HKG:0753, SHA:601111) completed a mainland-listed share issuance that raised net proceeds of about 20 billion yuan, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the firm were down nearly 3% in Thursday afternoon trade.The airline issued 3.04 billion shares at 6.57 yuan apiece to its controlling shareholder, China National Aviation, and its unit, China National Aviation Capital.The proceeds will be used for debt repayment and replenishing working capital, the company said.

$HKG:0753$SHA:601111